ArticleBlood advances2025

Anti-FcRL5 CAR-T exhibits anti-MM activity against EMM after progression of anti-BCMA and anti-GPRC5D CAR-T: a case report.

Xiaoyuan He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.